JP2016507526A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016507526A5 JP2016507526A5 JP2015556185A JP2015556185A JP2016507526A5 JP 2016507526 A5 JP2016507526 A5 JP 2016507526A5 JP 2015556185 A JP2015556185 A JP 2015556185A JP 2015556185 A JP2015556185 A JP 2015556185A JP 2016507526 A5 JP2016507526 A5 JP 2016507526A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- sulfasalazine
- composition according
- polymer
- pvp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 claims 11
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 claims 11
- 229960001940 sulfasalazine Drugs 0.000 claims 11
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 claims 11
- 208000015122 neurodegenerative disease Diseases 0.000 claims 8
- 229920000642 polymer Polymers 0.000 claims 7
- 238000000034 method Methods 0.000 claims 6
- 229920003083 Kollidon® VA64 Polymers 0.000 claims 4
- 206010053395 Progressive multiple sclerosis Diseases 0.000 claims 4
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 4
- 238000000338 in vitro Methods 0.000 claims 4
- 230000004770 neurodegeneration Effects 0.000 claims 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000010922 spray-dried dispersion Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361759933P | 2013-02-01 | 2013-02-01 | |
| US61/759,933 | 2013-02-01 | ||
| US201361780340P | 2013-03-13 | 2013-03-13 | |
| US61/780,340 | 2013-03-13 | ||
| PCT/US2014/014290 WO2014121137A2 (en) | 2013-02-01 | 2014-01-31 | Compositions and methods for the treatment of neurodegenerative and other diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018079284A Division JP2018123159A (ja) | 2013-02-01 | 2018-04-17 | 神経変性およびその他の疾患の治療用組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016507526A JP2016507526A (ja) | 2016-03-10 |
| JP2016507526A5 true JP2016507526A5 (enExample) | 2017-02-23 |
| JP6328146B2 JP6328146B2 (ja) | 2018-05-23 |
Family
ID=50382538
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015556185A Expired - Fee Related JP6328146B2 (ja) | 2013-02-01 | 2014-01-31 | 神経変性およびその他の疾患の治療用組成物および方法 |
| JP2018079284A Pending JP2018123159A (ja) | 2013-02-01 | 2018-04-17 | 神経変性およびその他の疾患の治療用組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018079284A Pending JP2018123159A (ja) | 2013-02-01 | 2018-04-17 | 神経変性およびその他の疾患の治療用組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US9597339B2 (enExample) |
| EP (1) | EP2950797B1 (enExample) |
| JP (2) | JP6328146B2 (enExample) |
| KR (1) | KR20150139830A (enExample) |
| CN (1) | CN105163735B (enExample) |
| AU (2) | AU2014212109B2 (enExample) |
| CA (1) | CA2899032A1 (enExample) |
| ES (1) | ES2752021T3 (enExample) |
| IL (1) | IL240206A0 (enExample) |
| WO (1) | WO2014121137A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2950797B1 (en) * | 2013-02-01 | 2019-09-11 | Glialogix, Inc. | Compositions and methods for the treatment of neurodegenerative and other diseases |
| KR102364840B1 (ko) * | 2014-11-05 | 2022-02-18 | 삼성전자주식회사 | 신경세포의 탈수초화와 연관된 질환을 치료하기 위한 약학적 조성물 및 그를 이용하는 방법 |
| US20160199393A1 (en) * | 2015-01-08 | 2016-07-14 | China Medical University | Methods of treating brain ischemia or hypoxia |
| ES2650175B1 (es) * | 2016-04-15 | 2019-02-04 | Servicio Andaluz De Salud | Tratamiento de enfermedades neurodegenerativas |
| US20190343860A1 (en) * | 2016-04-26 | 2019-11-14 | Saint Louis University | Highly selective adenosine a3 receptor subtype agonists for the prevention and treatment of neurodegenerative disorders |
| WO2018075865A1 (en) * | 2016-10-21 | 2018-04-26 | Glialogix, Inc. | Compositions for the treatment of neurodegenerative diseases |
| US10473672B2 (en) * | 2017-02-09 | 2019-11-12 | Kaohsiung Chang Gung Memorial Hospital | Methods for diagnosing and treating Alzheimers disease using G72 protein and SLC7A11 mRNA as biomarkers |
| RU2680844C1 (ru) * | 2017-10-12 | 2019-02-28 | федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) | Применение сульфасалазина в качестве ингибитора образования конечных продуктов гликирования |
| US11033506B2 (en) | 2017-11-21 | 2021-06-15 | Sekisui Chemical Co., Ltd. | External skin preparation comprising a core-shell structure |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2396145A (en) | 1940-12-14 | 1946-03-05 | Pharmscia Ab | Heterocyclic sulphonamido azo compounds |
| FR2608988B1 (fr) | 1986-12-31 | 1991-01-11 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules |
| KR970705979A (ko) | 1994-09-29 | 1997-11-03 | 디 히스 | 치료용 매개체로서의 분무-건조 미소입자 (Spray-dried microparticles as therapeutic vehicles) |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| ITMI962356A1 (it) | 1996-11-13 | 1998-05-13 | Uni Degli Studi Di Brescia D I | Uso di composti derivati da molecole ad attivita' antinfiammatoria di tipo non steroideo per la prevenzione e il trattamento di |
| ES2236832T3 (es) | 1997-01-16 | 2005-07-16 | Massachusetts Institute Of Technology | Preparacion de particulas para inhalacion. |
| CA2336139C (en) | 1998-06-24 | 2008-10-14 | Advanced Inhalation Research, Inc. | Large porous particles emitted from an inhaler |
| JP4416325B2 (ja) | 1998-08-25 | 2010-02-17 | アルカーメス，インコーポレイテッド | 安定な噴霧乾燥タンパク質製剤 |
| US6586008B1 (en) | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
| KR100417623B1 (ko) * | 2000-03-28 | 2004-02-05 | 주식회사 뉴로테크 | 뇌질환 예방 및 치료용 조성물 |
| CA2307278A1 (en) | 2000-04-28 | 2001-10-28 | University Of British Columbia | Use of n-heterocyclic substituted salicylic acids for inhibition of cellular uptake of cystine |
| JP2005523260A (ja) | 2002-02-01 | 2005-08-04 | ファイザー・プロダクツ・インク | 圧力ノズルを用いた均質噴霧乾燥固体非晶質薬剤分散体の製造方法 |
| KR100664822B1 (ko) | 2002-02-01 | 2007-01-04 | 화이자 프로덕츠 인코포레이티드 | 변형된 분무-건조 장치를 이용한 균질한 분무-건조된 고체비결정성 약물 분산액의 제조 방법 |
| CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
| US20060045865A1 (en) | 2004-08-27 | 2006-03-02 | Spherics, Inc. | Controlled regional oral delivery |
| WO2006049957A2 (en) | 2004-10-27 | 2006-05-11 | The Uab Research Foundation | Method for treating glioma |
| US8034765B2 (en) | 2005-08-31 | 2011-10-11 | Abraxis Bioscience, Llc | Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| US20070053869A1 (en) | 2005-09-02 | 2007-03-08 | Yuichi Sugiyama | Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| GB0602123D0 (en) * | 2006-02-02 | 2006-03-15 | Novartis Ag | Organic compounds |
| PT1983984T (pt) | 2006-02-02 | 2018-06-14 | Novartis Ag | Tratamento da esclerosa tuberosa |
| US7964585B2 (en) | 2006-03-14 | 2011-06-21 | Case Western Reserve University | Composition and method of treating peripheral neuropathy |
| MX2009002166A (es) | 2006-08-31 | 2009-03-12 | Eurand Inc | Sistema de distribucion de farmacos, que comprenden soluciones solidas de farmacos debilmente basicos. |
| US8309129B2 (en) | 2007-05-03 | 2012-11-13 | Bend Research, Inc. | Nanoparticles comprising a drug, ethylcellulose, and a bile salt |
| EP2231169B1 (en) | 2007-12-06 | 2016-05-04 | Bend Research, Inc. | Pharmaceutical compositions comprising nanoparticles and a resuspending material |
| EP2259777A2 (en) * | 2008-02-28 | 2010-12-15 | BIAL - Portela & Ca., S.A. | Pharmaceutical composition for poorly soluble drugs |
| DK2113254T3 (da) * | 2008-04-28 | 2012-12-03 | Txcell | Sammensætninger til behandling af en inflammatorisk autoimmun sygdom |
| TW201438738A (zh) * | 2008-09-16 | 2014-10-16 | 建南德克公司 | 治療進展型多發性硬化症之方法 |
| WO2010111132A2 (en) | 2009-03-27 | 2010-09-30 | Bend Research, Inc. | Spray-drying process |
| PT2611530T (pt) | 2010-09-03 | 2019-05-09 | Bend Res Inc | Aparelho de secagem por pulverização e métodos de utilização do mesmo |
| EP2611529B1 (en) | 2010-09-03 | 2019-01-23 | Bend Research, Inc. | Spray-drying method |
| HK1204970A1 (en) | 2012-01-31 | 2015-12-11 | Cerulean Pharma Inc. | Polymer-agent conjugates, particles, compositions, and related methods of use |
| EP2950797B1 (en) * | 2013-02-01 | 2019-09-11 | Glialogix, Inc. | Compositions and methods for the treatment of neurodegenerative and other diseases |
| EP3089736B1 (en) | 2013-12-31 | 2025-07-23 | Ascendia Pharmaceuticals, LLC | Pharmaceutical compositions for poorly water-soluble compounds |
-
2014
- 2014-01-31 EP EP14712798.9A patent/EP2950797B1/en active Active
- 2014-01-31 US US14/170,405 patent/US9597339B2/en not_active Expired - Fee Related
- 2014-01-31 WO PCT/US2014/014290 patent/WO2014121137A2/en not_active Ceased
- 2014-01-31 KR KR1020157023718A patent/KR20150139830A/ko not_active Withdrawn
- 2014-01-31 CA CA2899032A patent/CA2899032A1/en not_active Abandoned
- 2014-01-31 JP JP2015556185A patent/JP6328146B2/ja not_active Expired - Fee Related
- 2014-01-31 AU AU2014212109A patent/AU2014212109B2/en not_active Ceased
- 2014-01-31 ES ES14712798T patent/ES2752021T3/es active Active
- 2014-01-31 CN CN201480019892.8A patent/CN105163735B/zh not_active Expired - Fee Related
-
2015
- 2015-07-29 IL IL240206A patent/IL240206A0/en unknown
-
2016
- 2016-11-30 US US15/365,843 patent/US9980978B2/en not_active Expired - Fee Related
- 2016-11-30 US US15/365,835 patent/US9974798B2/en not_active Expired - Fee Related
-
2017
- 2017-02-10 US US15/430,294 patent/US9918997B2/en not_active Expired - Fee Related
-
2018
- 2018-04-17 US US15/955,020 patent/US10398713B2/en not_active Expired - Fee Related
- 2018-04-17 JP JP2018079284A patent/JP2018123159A/ja active Pending
- 2018-08-28 AU AU2018222921A patent/AU2018222921A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015120110A3 (en) | Novel pharmaceutical formulations | |
| MX370853B (es) | Formulaciones que contienen dapagliflozina amorfa. | |
| WO2015042078A8 (en) | Substituted aminopyrimidine compounds and methods of use | |
| WO2017132432A8 (en) | Benzimidazole derivatives as modulators of ror-gamma | |
| SG190448A1 (en) | Rapidly dispersing granules, orally disintegrating tablets and methods | |
| WO2011099832A3 (en) | Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same | |
| NZ728392A (en) | High dosage strength tablets of rucaparib | |
| WO2011072218A3 (en) | Stable formulations for lyophilizing therapeutic particles | |
| UA109868C2 (ru) | Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar) | |
| WO2013134047A3 (en) | Aminoquinoline derivatives and uses thereof | |
| NZ721952A (en) | Delayed release compositions of linaclotide | |
| TN2017000497A1 (en) | Orodispersible dosage unit containing an estetrol component | |
| HK1203815A1 (en) | Pharmaceutical compositions and methods for their preparation | |
| WO2014016548A3 (en) | Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient | |
| HK1215191A1 (zh) | 低剂量医药组合物 | |
| PH12013501437A1 (en) | Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases | |
| WO2014081581A3 (en) | Highly loaded amorphous efavirenz composition and process for preparing the same | |
| MX2016005764A (es) | Formulacion en suspension acuosa que comprende nanoparticulas de antibioticos macrolidos. | |
| WO2015173701A3 (en) | Pharmaceutical compositions comprising danirixin for treating infectious diseases | |
| HK1216839A1 (zh) | 调整释放制剂 | |
| MD4563B1 (ro) | Produs de comicronizare cu conţinut de acetat de ulipristal | |
| WO2012126441A3 (es) | Péptidos cíclicos con actividad antineoplásica y antiangiogénica. | |
| NZ727834A (en) | Fast acting orally disintegrating film | |
| WO2016040814A3 (en) | Disulfide polymers and methods of use | |
| EP4494705A3 (en) | Non-peptide oxytocin receptor agonists |